1. Home
  2. LEXX vs BWEN Comparison

LEXX vs BWEN Comparison

Compare LEXX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • BWEN
  • Stock Information
  • Founded
  • LEXX 2004
  • BWEN N/A
  • Country
  • LEXX Canada
  • BWEN United States
  • Employees
  • LEXX N/A
  • BWEN 444
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • LEXX Health Care
  • BWEN Industrials
  • Exchange
  • LEXX Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • LEXX 49.3M
  • BWEN 46.4M
  • IPO Year
  • LEXX N/A
  • BWEN N/A
  • Fundamental
  • Price
  • LEXX $3.13
  • BWEN $2.11
  • Analyst Decision
  • LEXX Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • LEXX 2
  • BWEN 3
  • Target Price
  • LEXX $11.00
  • BWEN $5.17
  • AVG Volume (30 Days)
  • LEXX 100.1K
  • BWEN 97.7K
  • Earning Date
  • LEXX 11-18-2024
  • BWEN 11-06-2024
  • Dividend Yield
  • LEXX N/A
  • BWEN N/A
  • EPS Growth
  • LEXX N/A
  • BWEN N/A
  • EPS
  • LEXX N/A
  • BWEN 0.35
  • Revenue
  • LEXX $411,019.00
  • BWEN $177,829,000.00
  • Revenue This Year
  • LEXX $82.02
  • BWEN N/A
  • Revenue Next Year
  • LEXX $95.09
  • BWEN $24.98
  • P/E Ratio
  • LEXX N/A
  • BWEN $6.10
  • Revenue Growth
  • LEXX 34.05
  • BWEN N/A
  • 52 Week Low
  • LEXX $0.85
  • BWEN $2.01
  • 52 Week High
  • LEXX $6.85
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 48.37
  • BWEN 42.06
  • Support Level
  • LEXX $2.91
  • BWEN $2.08
  • Resistance Level
  • LEXX $3.39
  • BWEN $2.35
  • Average True Range (ATR)
  • LEXX 0.19
  • BWEN 0.10
  • MACD
  • LEXX 0.00
  • BWEN 0.01
  • Stochastic Oscillator
  • LEXX 56.02
  • BWEN 12.96

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: